Atlas Trials

A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

Clinical trial NCT06182384 · COMPLETED

Trial details

NCT number
NCT06182384
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Moderate-to-Severe Plaque Psoriasis
Start date
2023-12-24
Primary completion
2024-05-13
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.